Incyte Corp. (NASDAQ: INCY) has seen a rise in its stock price by 0.39 in relation to its previous close of 66.17. However, the company has experienced a 1.62% gain in its stock price over the last five trading sessions. businesswire.com reported 2024-10-10 that WILMINGTON, Del.–(BUSINESS WIRE)—- $INCY–Incyte Furthers Commitment to People Living with Atopic Dermatitis by Sharing Additional Patient Experiences as part of its Moments of Clarity Program.
Is It Worth Investing in Incyte Corp. (NASDAQ: INCY) Right Now?
The price-to-earnings ratio for Incyte Corp. (NASDAQ: INCY) is 187.18x, which is above its average ratio. Moreover, the 36-month beta value for INCY is 0.73. Analysts have varying opinions on the stock, with 12 analysts rating it as a “buy,” 5 as “overweight,” 4 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for INCY is 190.25M and currently, short sellers hold a 3.57% of that float. On October 18, 2024, INCY’s average trading volume was 1.93M shares.
INCY’s Market Performance
INCY stock saw an increase of 1.62% in the past week, with a monthly gain of 1.93% and a quarterly increase of 0.85%. The volatility ratio for the week is 1.48%, and the volatility levels for the last 30 days are 2.12% for Incyte Corp. (INCY). The simple moving average for the last 20 days is 0.87% for INCY stock, with a simple moving average of 9.72% for the last 200 days.
Analysts’ Opinion of INCY
Many brokerage firms have already submitted their reports for INCY stocks, with Wolfe Research repeating the rating for INCY by listing it as a “Outperform.” The predicted price for INCY in the upcoming period, according to Wolfe Research is $84 based on the research report published on October 01, 2024 of the current year 2024.
Truist, on the other hand, stated in their research note that they expect to see INCY reach a price target of $74, previously predicting the price at $83. The rating they have provided for INCY stocks is “Hold” according to the report published on September 18th, 2024.
BMO Capital Markets gave a rating of “Underperform” to INCY, setting the target price at $48 in the report published on July 02nd of the current year.
INCY Trading at 2.83% from the 50-Day Moving Average
After a stumble in the market that brought INCY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -5.59% of loss for the given period.
Volatility was left at 2.12%, however, over the last 30 days, the volatility rate increased by 1.48%, as shares sank -0.58% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +10.18% upper at present.
During the last 5 trading sessions, INCY rose by +1.62%, which changed the moving average for the period of 200-days by +1.50% in comparison to the 20-day moving average, which settled at $65.86. In addition, Incyte Corp. saw 5.80% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at INCY starting from Tray Thomas, who sale 572 shares at the price of $62.94 back on Sep 12 ’24. After this action, Tray Thomas now owns 24,825 shares of Incyte Corp., valued at $36,002 using the latest closing price.
Tray Thomas, the Principal Accounting Officer of Incyte Corp., sale 382 shares at $63.37 during a trade that took place back on Sep 13 ’24, which means that Tray Thomas is holding 24,443 shares at $24,207 based on the most recent closing price.
Stock Fundamentals for INCY
Current profitability levels for the company are sitting at:
- 0.0 for the present operating margin
- 0.93 for the gross margin
The net margin for Incyte Corp. stands at 0.03. The total capital return value is set at 0.01. Equity return is now at value 2.51, with 1.79 for asset returns.
Based on Incyte Corp. (INCY), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at -1.63. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is 6.62.
Currently, EBITDA for the company is 904.74 million with net debt to EBITDA at -3.99. When we switch over and look at the enterprise to sales, we see a ratio of 3.07. The receivables turnover for the company is 5.22for trailing twelve months and the total asset turnover is 0.83. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.92.
Conclusion
To wrap up, the performance of Incyte Corp. (INCY) has been better in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
